|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn963677163 |
003 |
OCoLC |
005 |
20231120112155.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
161118s2016 enk o 001 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d N$T
|d YDX
|d OPELS
|d OCLCQ
|d IDEBK
|d OCLCQ
|d OTZ
|d OCLCQ
|d U3W
|d D6H
|d MERER
|d OCLCQ
|d NLW
|d S2H
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 962824635
|a 964546324
|a 1006320467
|a 1118428068
|a 1274949012
|
020 |
|
|
|a 0081006322
|q (electronic bk.)
|
020 |
|
|
|a 9780081006320
|q (electronic bk.)
|
020 |
|
|
|z 008100625X
|
020 |
|
|
|z 9780081006252
|
035 |
|
|
|a (OCoLC)963677163
|z (OCoLC)962824635
|z (OCoLC)964546324
|z (OCoLC)1006320467
|z (OCoLC)1118428068
|z (OCoLC)1274949012
|
050 |
|
4 |
|a RM301.25
|
060 |
|
4 |
|a QV 744
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.2
|2 23
|
245 |
0 |
0 |
|a Managing the drug discovery process :
|b how to make it more efficient and cost-effective /
|c Susan M. Miller [and others].
|
260 |
|
|
|a Kent :
|b Woodhead Publishing,
|c 2016.
|
300 |
|
|
|a 1 online resource (626 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Woodhead Publishing series in biomedicine
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Section I: Introduction and Overview 1. Backgrounder Section II: Pre-Professional Education 2. Pre-Professional Education: It Truly Takes a Village 3. Two-Year Certification Programs 4. Four-Year Undergraduate Degree Programs 5. The Big Decision Section III: Graduate and Professional Education 6. Graduate and Postgraduate Education: At a Crossroads 7. Master's Degree Programs 8. Doctoral and Professional Programs 9. The Big Leap Section IV: Research and Discovery 10. Organizational Aspects of Drug Discovery: Chaos Can Be Your Friend or Your Enemy 11. Drug Discovery: Standing on the Shoulders of Giants 12. Research and Discovery: The Difficult We Do Immediately -- The Impossible Takes Only a Little Longer Section V: Chemical Development, Quality Requirements, and Regulatory Affairs 13. Turning a Potent Agent into a Registered Product 14. Chemical Development: Synthetic Studies and Engineering Aspects 15. Chemical Development: Analytical Studies 16. FDA Path and Process: Sponsor's Regulatory Tasks for `Drug Approval Section VI: Pharmaceutical Research and Development -- Concluding Remarks 17. Epilogue
|
506 |
1 |
|
|a Legal Deposit;
|c Only available on premises controlled by the deposit library and to one user at any one time;
|e The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
|5 WlAbNL
|
540 |
|
|
|a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
|5 WlAbNL
|
650 |
|
0 |
|a Drug development
|x Management.
|
650 |
|
6 |
|a M�edicaments
|0 (CaQQLa)201-0306620
|x D�eveloppement
|0 (CaQQLa)201-0306620
|x Gestion.
|0 (CaQQLa)201-0380063
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
700 |
1 |
|
|a Miller, Susan M.
|
700 |
1 |
|
|a Moos, Walter.
|
776 |
0 |
8 |
|i Print version:
|t Managing the drug discovery process.
|d Kent : Woodhead Publishing, 2016
|z 9780081006252
|z 008100625X
|w (OCoLC)952982918
|
830 |
|
0 |
|a Woodhead Publishing series in biomedicine.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780081006252
|z Texto completo
|